(+)-alpha-tocopherol multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB mRNA, [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB protein CTD PMID:23859036 (+)-dihydromyricetin multiple interactions EXP 6480464 ampelopsin analog inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased phosphorylation of PDGFRB protein] CTD PMID:21871475 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [Carbon Tetrachloride results in increased expression of PDGFRB mRNA], epigallocatechin gallate inhibits the reaction [Carbon Tetrachloride results in increased expression of PDGFRB protein] CTD PMID:19646978 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:732897 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PDGFRB mRNA CTD PMID:22079256 (S)-nicotine multiple interactions EXP 6480464 Nicotine results in decreased phosphorylation of and results in decreased activity of PDGFRB protein CTD PMID:20447445 (S)-nicotine increases expression ISO RGD:732897 6480464 Nicotine results in increased expression of PDGFRB protein CTD PMID:16149045 (S)-nicotine multiple interactions ISO RGD:732897 6480464 6, 7-dimethoxy-2-phenylquinoxaline inhibits the reaction [Nicotine results in increased expression of PDGFRB protein] CTD PMID:16149045 1-naphthyl isothiocyanate multiple interactions ISO RGD:732897 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of PDGFRB mRNA CTD PMID:27344345 1-nitropyrene decreases expression ISO RGD:732897 6480464 1-nitropyrene results in decreased expression of PDGFRB mRNA CTD PMID:19041380 17alpha-ethynylestradiol multiple interactions ISO RGD:11070 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PDGFRB mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of PDGFRB mRNA CTD PMID:17557909 17beta-estradiol multiple interactions ISO RGD:732897 6480464 [Progesterone co-treated with Estradiol] results in increased expression of PDGFRB mRNA CTD PMID:18692832 2,2-(2-Chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene multiple interactions ISO RGD:732897 6480464 [Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2 more ... CTD PMID:19422813 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:11070 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PDGFRB mRNA more ... CTD PMID:15034205 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:11070 6480464 Tetrachlorodibenzodioxin results in decreased expression of PDGFRB mRNA CTD PMID:18691609 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:11070 6480464 Tetrachlorodibenzodioxin affects the expression of PDGFRB mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732897 6480464 Tetrachlorodibenzodioxin results in decreased expression of PDGFRB mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:11070 6480464 Tetrachlorodibenzodioxin results in increased expression of PDGFRB mRNA CTD PMID:15034205 , PMID:20819909 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732897 6480464 Tetrachlorodibenzodioxin affects the expression of PDGFRB mRNA CTD PMID:22298810 2-methylcholine affects expression ISO RGD:732897 6480464 beta-methylcholine affects the expression of PDGFRB mRNA CTD PMID:21179406 3,4-methylenedioxymethamphetamine increases expression ISO RGD:11070 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of PDGFRB mRNA CTD PMID:20188158 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions ISO RGD:732897 6480464 bisindolylmaleimide I inhibits the reaction [Leukotriene D4 results in increased phosphorylation of and results in increased activity of PDGFRB protein] CTD PMID:12223454 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:11070 6480464 [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PDGFRB mRNA more ... CTD PMID:16054899 4,4'-sulfonyldiphenol increases expression ISO RGD:11070 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PDGFRB mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine increases expression ISO RGD:732897 6480464 Decitabine results in increased expression of PDGFRB mRNA CTD PMID:21856257 6,7-dimethoxy-2-phenylquinoxaline multiple interactions ISO RGD:732897 6480464 6 more ... CTD PMID:16149045 , PMID:25896968 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions EXP 6480464 6-chloro-2 more ... CTD PMID:31981641 acetamide increases expression EXP 6480464 acetamide results in increased expression of PDGFRB mRNA CTD PMID:31881176 aldrin multiple interactions ISO RGD:732897 6480464 [Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2 more ... CTD PMID:19422813 , PMID:28263720 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of PDGFRB mRNA alternative form CTD PMID:17303670 all-trans-retinoic acid multiple interactions ISO RGD:11070 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of PDGFRB mRNA CTD PMID:30951980 all-trans-retinoic acid increases expression ISO RGD:732897 6480464 Tretinoin results in increased expression of PDGFRB mRNA CTD PMID:23724009 all-trans-retinoic acid increases expression ISO RGD:11070 6480464 Tretinoin results in increased expression of PDGFRB mRNA, Tretinoin results in increased expression of PDGFRB protein CTD PMID:21295132 allyl isothiocyanate decreases expression ISO RGD:11070 6480464 allyl isothiocyanate results in decreased expression of PDGFRB mRNA CTD PMID:24036144 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PDGFRB mRNA CTD PMID:16483693 anthra[1,9-cd]pyrazol-6(2H)-one decreases expression EXP 6480464 pyrazolanthrone results in decreased expression of PDGFRB mRNA, pyrazolanthrone results in decreased expression of PDGFRB protein CTD PMID:18332871 antirheumatic drug increases expression ISO RGD:732897 6480464 Antirheumatic Agents results in increased expression of PDGFRB mRNA CTD PMID:24449571 arsane affects expression ISO RGD:732897 6480464 Arsenic affects the expression of PDGFRB mRNA CTD PMID:30746931 arsenic atom affects expression ISO RGD:732897 6480464 Arsenic affects the expression of PDGFRB mRNA CTD PMID:30746931 arsenous acid increases expression ISO RGD:732897 6480464 Arsenic Trioxide results in increased expression of PDGFRB mRNA CTD PMID:29633893 atrazine increases expression ISO RGD:732897 6480464 Atrazine results in increased expression of PDGFRB mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:11070 6480464 Benzo(a)pyrene results in decreased expression of PDGFRB mRNA CTD PMID:21569818 benzo[a]pyrene increases expression ISO RGD:732897 6480464 Benzo(a)pyrene results in increased expression of PDGFRB mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:732897 6480464 Benzo(a)pyrene affects the methylation of PDGFRB intron CTD PMID:30157460 benzo[a]pyrene decreases methylation ISO RGD:732897 6480464 Benzo(a)pyrene results in decreased methylation of PDGFRB promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:732897 6480464 Benzo(a)pyrene results in increased methylation of PDGFRB 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:732897 6480464 Benzo(a)pyrene results in decreased expression of PDGFRB mRNA CTD PMID:22316170 , PMID:26238291 benzo[a]pyrene multiple interactions ISO RGD:11070 6480464 AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of PDGFRB mRNA] CTD PMID:15034205 benzo[a]pyrene increases expression ISO RGD:11070 6480464 Benzo(a)pyrene results in increased expression of PDGFRB mRNA CTD PMID:15034205 , PMID:22228805 benzoates decreases expression ISO RGD:732897 6480464 Benzoates analog results in decreased expression of PDGFRB protein CTD PMID:29472718 beta-carotene multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB mRNA, [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB protein CTD PMID:23859036 beta-hexachlorocyclohexane decreases expression ISO RGD:11070 6480464 beta-hexachlorocyclohexane results in decreased expression of PDGFRB mRNA CTD PMID:25270620 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:732897 6480464 IL10 protein affects the reaction [Mustard Gas affects the expression of PDGFRB mRNA] CTD PMID:16173061 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PDGFRB mRNA, bisphenol A results in increased expression of PDGFRB protein CTD PMID:12604637 , PMID:29097150 bisphenol A increases expression ISO RGD:11070 6480464 bisphenol A results in increased expression of PDGFRB mRNA CTD PMID:30951980 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PDGFRB gene CTD PMID:28505145 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in decreased methylation of PDGFRB gene, [bisphenol A co-treated with Genistein] results in increased methylation of PDGFRB gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PDGFRB mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A decreases expression ISO RGD:11070 6480464 bisphenol A results in decreased expression of PDGFRB mRNA CTD PMID:26063408 bisphenol F multiple interactions ISO RGD:11070 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of PDGFRB mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:11070 6480464 bisphenol F results in increased expression of PDGFRB mRNA CTD PMID:30951980 bortezomib multiple interactions ISO RGD:732897 6480464 [Bortezomib co-treated with sorafenib] results in decreased phosphorylation of PDGFRB protein CTD PMID:16985072 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of PDGFRB mRNA CTD PMID:32479839 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of PDGFRB mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO RGD:732897 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PDGFRB mRNA CTD PMID:29741670 cadmium dichloride multiple interactions ISO RGD:732897 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PDGFRB mRNA CTD PMID:29741670 calciol increases expression ISO RGD:11070 6480464 Cholecalciferol results in increased expression of PDGFRB mRNA CTD PMID:17170073 captan multiple interactions ISO RGD:11070 6480464 [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of PDGFRB protein CTD PMID:32736067 carbon nanotube decreases expression ISO RGD:11070 6480464 Nanotubes, Carbon analog results in decreased expression of PDGFRB mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:11070 6480464 Nanotubes, Carbon results in increased expression of PDGFRB mRNA CTD PMID:25926378 chlorpyrifos multiple interactions ISO RGD:11070 6480464 [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of PDGFRB protein CTD PMID:32736067 choline multiple interactions ISO RGD:11070 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PDGFRB mRNA CTD PMID:20938992 chondroitin sulfate multiple interactions ISO RGD:732897 6480464 Chondroitin Sulfates promotes the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of PDGFRB protein], Genistein inhibits the reaction [Chondroitin Sulfates promotes the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of PDGFRB protein]] CTD PMID:16945567 chromium(6+) multiple interactions ISO RGD:11070 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of PDGFRB mRNA, SHH protein affects the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of PDGFRB mRNA] CTD PMID:31756458 cisplatin decreases expression ISO RGD:11070 6480464 Cisplatin results in decreased expression of PDGFRB mRNA CTD PMID:21151649 copper atom multiple interactions ISO RGD:732897 6480464 [Disulfiram binds to Copper] which results in increased expression of PDGFRB mRNA CTD PMID:24690739 copper(0) multiple interactions ISO RGD:732897 6480464 [Disulfiram binds to Copper] which results in increased expression of PDGFRB mRNA CTD PMID:24690739 copper(II) sulfate decreases expression ISO RGD:732897 6480464 Copper Sulfate results in decreased expression of PDGFRB mRNA CTD PMID:19549813 copper(II) sulfate multiple interactions ISO RGD:732897 6480464 Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of PDGFRB mRNA] more ... CTD PMID:23392711 copper(II) sulfate increases expression ISO RGD:732897 6480464 Copper Sulfate results in increased expression of PDGFRB mRNA, Copper Sulfate results in increased expression of PDGFRB protein CTD PMID:23392711 coumestrol increases expression EXP 6480464 Coumestrol results in increased expression of PDGFRB mRNA, Coumestrol results in increased expression of PDGFRB protein CTD PMID:12604637 crocidolite asbestos decreases expression ISO RGD:732897 6480464 Asbestos, Crocidolite results in decreased expression of PDGFRB mRNA CTD PMID:28056339 curcumin increases expression ISO RGD:732897 6480464 Curcumin results in increased expression of PDGFRB mRNA CTD PMID:21594647 curcumin decreases phosphorylation EXP 6480464 Curcumin results in decreased phosphorylation of PDGFRB protein CTD PMID:17372590 , PMID:18332871 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Carbon Tetrachloride results in increased expression of PDGFRB mRNA] CTD PMID:18006644 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of PDGFRB mRNA, Curcumin results in decreased expression of PDGFRB protein CTD PMID:18332871 cyclosporin A increases expression ISO RGD:732897 6480464 Cyclosporine results in increased expression of PDGFRB mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO RGD:732897 6480464 Cyclosporine results in decreased expression of PDGFRB mRNA CTD PMID:25562108 cytarabine decreases expression ISO RGD:732897 6480464 Cytarabine results in decreased expression of PDGFRB mRNA CTD PMID:21198554 DDD multiple interactions ISO RGD:732897 6480464 [Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2 more ... CTD PMID:19422813 , PMID:28263720 DDE multiple interactions ISO RGD:732897 6480464 [Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2 more ... CTD PMID:19422813 , PMID:28263720 DDT multiple interactions ISO RGD:732897 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in increased expression of PDGFRB mRNA CTD PMID:28263720 dermatan sulfate decreases expression ISO RGD:732897 6480464 Dermatan Sulfate results in decreased expression of PDGFRB mRNA CTD PMID:16945567 desferrioxamine B decreases expression EXP 6480464 Deferoxamine results in decreased expression of PDGFRB protein CTD PMID:18032466 dexamethasone multiple interactions ISO RGD:11070 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PDGFRB mRNA more ... CTD PMID:16054899 dexamethasone decreases expression ISO RGD:11070 6480464 Dexamethasone results in decreased expression of PDGFRB mRNA CTD PMID:22733784 dextran sulfate multiple interactions ISO RGD:11070 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PDGFRB mRNA CTD PMID:29950665 diarsenic trioxide increases expression ISO RGD:732897 6480464 Arsenic Trioxide results in increased expression of PDGFRB mRNA CTD PMID:29633893 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of PDGFRB mRNA CTD PMID:21266533 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] affects the expression of PDGFRB mRNA CTD PMID:18636392 diclofenac decreases expression ISO RGD:11070 6480464 Diclofenac results in decreased expression of PDGFRB mRNA CTD PMID:26934552 dicrotophos increases expression ISO RGD:732897 6480464 dicrotophos results in increased expression of PDGFRB mRNA CTD PMID:28302478 dieldrin multiple interactions ISO RGD:732897 6480464 [Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2 more ... CTD PMID:19422813 , PMID:28263720 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of PDGFRB mRNA, Diethylstilbestrol results in increased expression of PDGFRB protein CTD PMID:12604637 dioxygen multiple interactions ISO RGD:11070 6480464 Oxygen deficiency results in increased expression of and results in increased activity of PDGFRB protein, rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased activity of PDGFRB protein] CTD PMID:19520921 disodium selenite multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB mRNA, [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB protein CTD PMID:23859036 disulfiram multiple interactions ISO RGD:732897 6480464 [Disulfiram binds to Copper] which results in increased expression of PDGFRB mRNA CTD PMID:24690739 doxorubicin affects expression ISO RGD:732897 6480464 Doxorubicin affects the expression of PDGFRB mRNA CTD PMID:29803840 emodin multiple interactions EXP 6480464 Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein] CTD PMID:15288473 emodin decreases expression EXP 6480464 Emodin results in decreased expression of PDGFRB protein CTD PMID:15288473 Endrin multiple interactions ISO RGD:732897 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in increased expression of PDGFRB mRNA CTD PMID:28263720 entinostat decreases expression ISO RGD:11070 6480464 entinostat results in decreased expression of PDGFRB protein CTD PMID:29845424 ethanol multiple interactions EXP 6480464 fomepizole inhibits the reaction [Ethanol results in increased expression of PDGFRB mRNA] CTD PMID:20116195 ethanol increases expression ISO RGD:11070 6480464 Ethanol results in increased expression of PDGFRB mRNA CTD PMID:30319688 ethanol increases expression EXP 6480464 Ethanol results in increased expression of PDGFRB mRNA CTD PMID:20116195 fenamidone increases expression ISO RGD:11070 6480464 fenamidone results in increased expression of PDGFRB mRNA CTD PMID:27029645 flutamide increases expression EXP 6480464 Flutamide results in increased expression of PDGFRB mRNA CTD PMID:20566332 folic acid multiple interactions ISO RGD:11070 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PDGFRB mRNA CTD PMID:20938992 folic acid decreases expression ISO RGD:732897 6480464 Folic Acid results in decreased expression of PDGFRB mRNA CTD PMID:21867686 fomepizole multiple interactions EXP 6480464 fomepizole inhibits the reaction [Ethanol results in increased expression of PDGFRB mRNA] CTD PMID:20116195 furan increases expression EXP 6480464 furan results in increased expression of PDGFRB mRNA CTD PMID:27387713 furosemide increases expression EXP 6480464 Furosemide results in increased expression of PDGFRB mRNA CTD PMID:16526316 gamma-hexachlorocyclohexane multiple interactions ISO RGD:732897 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in increased expression of PDGFRB mRNA CTD PMID:28263720 genistein increases expression EXP 6480464 Genistein results in increased expression of PDGFRB mRNA, Genistein results in increased expression of PDGFRB protein CTD PMID:12604637 genistein multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in decreased methylation of PDGFRB gene, [bisphenol A co-treated with Genistein] results in increased methylation of PDGFRB gene CTD PMID:28505145 genistein decreases expression ISO RGD:732897 6480464 Genistein results in decreased expression of PDGFRB mRNA CTD PMID:22228119 genistein multiple interactions ISO RGD:732897 6480464 Genistein inhibits the reaction [Chondroitin Sulfates promotes the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of PDGFRB protein]] CTD PMID:16945567 glutathione increases abundance ISO RGD:732897 6480464 PDGFRB protein results in increased abundance of Glutathione CTD PMID:29857117 GW 4064 multiple interactions ISO RGD:11070 6480464 GW 4064 promotes the reaction [NR1H4 protein binds to PDGFRB gene] CTD PMID:20091679 hemin multiple interactions ISO RGD:732897 6480464 [hydroquinone co-treated with Hemin] affects the expression of PDGFRB mRNA CTD PMID:32198055 hydrogen peroxide affects expression ISO RGD:732897 6480464 Hydrogen Peroxide affects the expression of PDGFRB mRNA CTD PMID:20044591 hydrogen peroxide multiple interactions EXP 6480464 tetramethylpyrazine inhibits the reaction [Hydrogen Peroxide results in increased expression of PDGFRB mRNA], tetramethylpyrazine inhibits the reaction [Hydrogen Peroxide results in increased expression of PDGFRB protein] CTD PMID:23022513 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of PDGFRB mRNA, Hydrogen Peroxide results in increased expression of PDGFRB protein CTD PMID:23022513 hydrogen peroxide multiple interactions ISO RGD:11070 6480464 [Hydrogen Peroxide affects the activity of PDGFRB protein] which results in increased activity of MAPK1 protein more ... CTD PMID:14975446 hydroquinone multiple interactions ISO RGD:732897 6480464 [hydroquinone co-treated with Hemin] affects the expression of PDGFRB mRNA CTD PMID:32198055 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of PDGFRB mRNA CTD PMID:17440234 isotretinoin increases expression ISO RGD:732897 6480464 Isotretinoin results in increased expression of PDGFRB mRNA CTD PMID:20436886 L-ascorbic acid multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB mRNA, [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB protein CTD PMID:23859036 L-cysteine multiple interactions EXP 6480464 Cysteine inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein], Cysteine inhibits the reaction [Thioacetamide results in increased expression of PDGFRB protein] CTD PMID:15158331 L-cysteine decreases expression EXP 6480464 Cysteine results in decreased expression of PDGFRB protein CTD PMID:15158331 L-methionine multiple interactions EXP 6480464 Methionine inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein], Methionine inhibits the reaction [Thioacetamide results in increased expression of PDGFRB protein] CTD PMID:15158331 L-methionine multiple interactions ISO RGD:11070 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PDGFRB mRNA CTD PMID:20938992 L-methionine decreases expression EXP 6480464 Methionine results in decreased expression of PDGFRB protein CTD PMID:15158331 lercanidipine decreases phosphorylation EXP 6480464 lercanidipine results in decreased phosphorylation of PDGFRB protein CTD PMID:18973813 leukotriene D4 multiple interactions ISO RGD:732897 6480464 6 more ... CTD PMID:12223454 lipopolysaccharide decreases expression ISO RGD:11070 6480464 Lipopolysaccharides results in decreased expression of PDGFRB mRNA CTD PMID:12057914 lipopolysaccharide increases expression ISO RGD:11070 6480464 Lipopolysaccharides results in increased expression of PDGFRB mRNA CTD PMID:27339419 lipoxin A4 multiple interactions ISO RGD:732897 6480464 lipoxin A4 affects the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein] more ... CTD PMID:12223454 , PMID:20709806 lipoxin A4 decreases phosphorylation ISO RGD:732897 6480464 lipoxin A4 results in decreased phosphorylation of PDGFRB protein CTD PMID:20709806 losartan multiple interactions EXP 6480464 Losartan inhibits the reaction [AGT protein results in increased expression of PDGFRB mRNA] CTD PMID:17043664 melittin multiple interactions EXP 6480464 Melitten results in decreased phosphorylation of and results in decreased activity of PDGFRB protein CTD PMID:17654254 methylisothiazolinone decreases expression ISO RGD:732897 6480464 2-methyl-4-isothiazolin-3-one results in decreased expression of PDGFRB mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:732897 6480464 methylmercuric chloride results in increased expression of PDGFRB mRNA CTD PMID:28001369 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of PDGFRB mRNA CTD PMID:25972201 N-acetyl-L-cysteine multiple interactions ISO RGD:11070 6480464 Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of PDGFRB mRNA] CTD PMID:21134390 N-acetyl-L-cysteine multiple interactions ISO RGD:732897 6480464 Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of PDGFRB mRNA] more ... CTD PMID:23392711 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in increased expression of PDGFRB mRNA CTD PMID:20360939 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of PDGFRB mRNA, Diethylnitrosamine results in increased expression of PDGFRB protein CTD PMID:19638242 , PMID:26589970 nicotine multiple interactions ISO RGD:732897 6480464 6, 7-dimethoxy-2-phenylquinoxaline inhibits the reaction [Nicotine results in increased expression of PDGFRB protein] CTD PMID:16149045 nicotine increases expression ISO RGD:732897 6480464 Nicotine results in increased expression of PDGFRB protein CTD PMID:16149045 nicotine multiple interactions EXP 6480464 Nicotine results in decreased phosphorylation of and results in decreased activity of PDGFRB protein CTD PMID:20447445 nitrofen multiple interactions EXP 6480464 Imatinib Mesylate inhibits the reaction [nitrofen results in increased expression of PDGFRB protein] CTD PMID:22447953 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of PDGFRB protein CTD PMID:22447953 Nonylphenol decreases expression EXP 6480464 nonylphenol results in decreased expression of PDGFRB mRNA CTD PMID:15518916 olmesartan multiple interactions EXP 6480464 olmesartan inhibits the reaction [Carbon Tetrachloride results in increased expression of PDGFRB protein], olmesartan inhibits the reaction [Fish Oils inhibits the reaction [Carbon Tetrachloride results in increased expression of PDGFRB protein]] CTD PMID:24144775 orantinib multiple interactions ISO RGD:732897 6480464 orantinib results in decreased phosphorylation of and results in decreased activity of PDGFRB protein CTD PMID:16144927 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of PDGFRB mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PDGFRB mRNA CTD PMID:25729387 oxidopamine decreases expression EXP 6480464 Oxidopamine results in decreased expression of PDGFRB mRNA CTD PMID:15518916 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] affects the expression of PDGFRB mRNA CTD PMID:18636392 paracetamol affects expression ISO RGD:11070 6480464 Acetaminophen affects the expression of PDGFRB mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:732897 6480464 Acetaminophen results in increased expression of PDGFRB mRNA CTD PMID:29067470 pentane-2,3-dione increases expression EXP 6480464 2, 3-pentanedione results in increased expression of PDGFRB mRNA CTD PMID:25710175 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of PDGFRB mRNA CTD PMID:28511854 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in increased expression of PDGFRB mRNA CTD PMID:20360939 phenobarbital affects expression ISO RGD:11070 6480464 Phenobarbital affects the expression of PDGFRB mRNA CTD PMID:23091169 pirinixic acid decreases expression ISO RGD:11070 6480464 pirinixic acid results in decreased expression of PDGFRB mRNA CTD PMID:18445702 pirinixic acid increases expression ISO RGD:11070 6480464 pirinixic acid results in increased expression of PDGFRB mRNA CTD PMID:17426115 ponatinib decreases activity ISO RGD:732897 6480464 ponatinib analog results in decreased activity of PDGFRB protein, ponatinib results in decreased activity of PDGFRB protein CTD PMID:19878872 , PMID:21561767 potassium chromate decreases expression ISO RGD:732897 6480464 potassium chromate(VI) results in decreased expression of PDGFRB mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:732897 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PDGFRB mRNA CTD PMID:22079256 potassium dichromate multiple interactions ISO RGD:11070 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of PDGFRB mRNA, SHH protein affects the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of PDGFRB mRNA] CTD PMID:31756458 progesterone multiple interactions ISO RGD:732897 6480464 [Progesterone co-treated with Estradiol] results in increased expression of PDGFRB mRNA CTD PMID:18692832 raloxifene affects expression ISO RGD:732897 6480464 Raloxifene Hydrochloride affects the expression of PDGFRB mRNA CTD PMID:14699072 reactive oxygen species decreases abundance ISO RGD:732897 6480464 PDGFRB protein results in decreased abundance of Reactive Oxygen Species CTD PMID:29857117 resveratrol multiple interactions ISO RGD:732897 6480464 resveratrol inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased phosphorylation of PDGFRB protein], resveratrol inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein] CTD PMID:16343977 , PMID:23457620 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of PDGFRB mRNA CTD PMID:28374803 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO RGD:732897 6480464 Buthionine Sulfoximine inhibits the reaction [Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of PDGFRB mRNA]], Buthionine Sulfoximine inhibits the reaction [Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of PDGFRB protein]] CTD PMID:23392711 Salinomycin decreases expression ISO RGD:732897 6480464 salinomycin results in decreased expression of PDGFRB mRNA CTD PMID:19682730 simvastatin decreases expression ISO RGD:11070 6480464 Simvastatin results in decreased expression of PDGFRB mRNA CTD PMID:10412775 simvastatin multiple interactions ISO RGD:732897 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in increased expression of PDGFRB mRNA CTD PMID:28263720 sodium arsenite multiple interactions ISO RGD:11070 6480464 Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of PDGFRB mRNA] CTD PMID:21134390 sodium arsenite increases expression ISO RGD:11070 6480464 sodium arsenite results in increased expression of PDGFRB mRNA CTD PMID:21134390 sodium arsenite decreases expression ISO RGD:11070 6480464 sodium arsenite results in decreased expression of PDGFRB mRNA CTD PMID:16014739 sodium chloride increases expression ISO RGD:732897 6480464 Sodium Chloride results in increased expression of PDGFRB mRNA CTD PMID:23634900 sorafenib multiple interactions EXP 6480464 sorafenib results in decreased phosphorylation of and results in decreased activity of PDGFRB protein CTD PMID:19338580 sorafenib decreases expression EXP 6480464 sorafenib results in decreased expression of PDGFRB mRNA CTD PMID:19338580 sorafenib decreases phosphorylation ISO RGD:732897 6480464 sorafenib results in decreased phosphorylation of PDGFRB protein CTD PMID:19139124 sorafenib decreases activity ISO RGD:732897 6480464 sorafenib results in decreased activity of PDGFRB protein mutant form CTD PMID:17229632 sorafenib multiple interactions ISO RGD:732897 6480464 [Bortezomib co-treated with sorafenib] results in decreased phosphorylation of PDGFRB protein CTD PMID:16985072 sulforaphane decreases expression ISO RGD:732897 6480464 sulforafan results in decreased expression of PDGFRB mRNA CTD PMID:31838189 tanespimycin decreases expression ISO RGD:732897 6480464 tanespimycin results in decreased expression of PDGFRB protein CTD PMID:22810956 tanespimycin decreases expression EXP 6480464 tanespimycin results in decreased expression of PDGFRB protein CTD PMID:22810956 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of PDGFRB mRNA CTD PMID:21515302 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of PDGFRB mRNA, Carbon Tetrachloride results in increased expression of PDGFRB protein CTD PMID:15623374 more ... tetrachloromethane multiple interactions ISO RGD:11070 6480464 F2R protein affects the reaction [Carbon Tetrachloride results in increased expression of PDGFRB mRNA] more ... CTD PMID:17962354 more ... tetrachloromethane increases expression ISO RGD:11070 6480464 Carbon Tetrachloride results in increased expression of PDGFRB mRNA, Carbon Tetrachloride results in increased expression of PDGFRB protein CTD PMID:17962354 more ... tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PDGFRB protein CTD PMID:17069927 tetrachloromethane multiple interactions EXP 6480464 Curcumin inhibits the reaction [Carbon Tetrachloride results in increased expression of PDGFRB mRNA] more ... CTD PMID:18006644 more ... tetramethylpyrazine multiple interactions EXP 6480464 tetramethylpyrazine inhibits the reaction [Hydrogen Peroxide results in increased expression of PDGFRB mRNA], tetramethylpyrazine inhibits the reaction [Hydrogen Peroxide results in increased expression of PDGFRB protein] CTD PMID:23022513 tetramethylpyrazine multiple interactions ISO RGD:11070 6480464 NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of PDGFRB mRNA]] more ... CTD PMID:27477297 tetraphene increases expression ISO RGD:11070 6480464 benz(a)anthracene results in increased expression of PDGFRB mRNA CTD PMID:26377693 tetrathiomolybdate(2-) decreases expression ISO RGD:732897 6480464 tetrathiomolybdate results in decreased expression of PDGFRB protein CTD PMID:18480265 thiacloprid multiple interactions ISO RGD:11070 6480464 [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of PDGFRB protein CTD PMID:32736067 thioacetamide multiple interactions EXP 6480464 Cysteine inhibits the reaction [Thioacetamide results in increased expression of PDGFRB protein] more ... CTD PMID:15158331 more ... thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PDGFRB protein CTD PMID:15158331 , PMID:15288473 thiophanate-methyl multiple interactions ISO RGD:11070 6480464 [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of PDGFRB protein CTD PMID:32736067 titanium dioxide multiple interactions ISO RGD:11070 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PDGFRB mRNA CTD PMID:29950665 toluene increases expression EXP 6480464 Toluene results in increased expression of PDGFRB mRNA CTD PMID:22967744 topotecan increases expression EXP 6480464 Topotecan results in increased expression of PDGFRB mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PDGFRB mRNA CTD PMID:25729387 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of PDGFRB mRNA CTD PMID:30589522 tris(2-butoxyethyl) phosphate affects expression ISO RGD:732897 6480464 tris(2-butoxyethyl) phosphate affects the expression of PDGFRB mRNA CTD PMID:29024780 troglitazone decreases expression ISO RGD:11070 6480464 troglitazone results in decreased expression of PDGFRB mRNA CTD PMID:28973697 tunicamycin decreases expression ISO RGD:732897 6480464 Tunicamycin results in decreased expression of PDGFRB mRNA CTD PMID:22378314 valproic acid increases methylation ISO RGD:732897 6480464 Valproic Acid results in increased methylation of PDGFRB gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:11070 6480464 Valproic Acid results in decreased expression of PDGFRB protein CTD PMID:29845424 valproic acid increases expression ISO RGD:11070 6480464 Valproic Acid results in increased expression of PDGFRB mRNA CTD PMID:24896083 valproic acid decreases expression ISO RGD:732897 6480464 Valproic Acid results in decreased expression of PDGFRB mRNA CTD PMID:29154799 vancomycin decreases expression ISO RGD:11070 6480464 Vancomycin results in decreased expression of PDGFRB mRNA CTD PMID:18930951 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of PDGFRB mRNA CTD PMID:20566332 vitamin E multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB mRNA, [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB protein CTD PMID:23859036 vitamin E increases expression ISO RGD:732897 6480464 Vitamin E results in increased expression of PDGFRB mRNA CTD PMID:19244175 Y-27632 multiple interactions EXP 6480464 Y 27632 inhibits the reaction [Carbon Tetrachloride results in increased expression of PDGFRB mRNA] CTD PMID:30783172 zinc atom multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB mRNA, [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB protein CTD PMID:23859036 zinc(0) multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB mRNA, [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB protein CTD PMID:23859036 ziram multiple interactions ISO RGD:11070 6480464 [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of PDGFRB protein CTD PMID:32736067
Biological Process adrenal gland development ISO RGD:11070 1624291 MGI:MGI:97530 (MGI:MGI:3820330 , PMID:19056881) RGD MGI:MGI:3820330 , PMID:19056881 aging IEP 11080972 RGD aorta morphogenesis ISO RGD:11070 1624291 UniProtKB:Q91ZX7 (MGI:MGI:4365879 , PMID:19742316) RGD MGI:MGI:4365879 , PMID:19742316 blood vessel development ISO RGD:11070 1624291 (PMID:10375497) RGD PMID:10375497 cardiac myofibril assembly ISO RGD:11070 1624291 UniProtKB:P26618 (MGI:MGI:1931346 , PMID:11239463) RGD MGI:MGI:1931346 , PMID:11239463 cardiac myofibril assembly ISS UniProtKB:P05622 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cell chemotaxis ISO RGD:732897 1624291 (PMID:17991872), (PMID:2554309) RGD PMID:17991872 , PMID:2554309 cell chemotaxis ISS UniProtKB:P09619 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cell migration ISO RGD:732897 1624291 (PMID:2554309) RGD PMID:2554309 cell migration ISS UniProtKB:P09619 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cell migration involved in coronary angiogenesis ISO RGD:11070 1624291 (MGI:MGI:2680741, PMID:14624252) RGD MGI:MGI:2680741 , PMID:14624252 cell migration involved in coronary angiogenesis ISS UniProtKB:P05622 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cell migration involved in vasculogenesis ISO RGD:11070 1624291 (MGI:MGI:2680741, PMID:14624252) RGD MGI:MGI:2680741 , PMID:14624252 cell migration involved in vasculogenesis ISS UniProtKB:P05622 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cellular response to hydrogen peroxide ISO RGD:11070 1624291 (MGI:MGI:5518963, PMID:23651497) RGD MGI:MGI:5518963 , PMID:23651497 cellular response to platelet-derived growth factor stimulus IEA GO:0005017 1600115 GO_REF:0000108 GOC GO_REF:0000108 embryonic organ development ISO RGD:11070 1624291 (PMID:10375497) RGD PMID:10375497 glycosaminoglycan biosynthetic process IMP 1581762 RGD hemopoiesis NOT ISO RGD:11070 1624291 (MGI:MGI:1932685, PMID:11264163) RGD MGI:MGI:1932685 , PMID:11264163 hemopoiesis NOT ISS UniProtKB:P05622 1600115 GO_REF:0000024 UniProt GO_REF:0000024 in utero embryonic development ISO RGD:11070 1624291 MGI:MGI:2135508 (MGI:MGI:3696608 , PMID:17143286) RGD MGI:MGI:3696608 , PMID:17143286 inner ear development IEP 2292167 RGD intracellular signal transduction IMP 2292196 RGD kidney development ISO RGD:11070 1624291 MGI:MGI:2135508 (MGI:MGI:3696608 , PMID:17143286) RGD MGI:MGI:3696608 , PMID:17143286 lung growth IMP 11087558 RGD male gonad development IEP 11087559 RGD metanephric comma-shaped body morphogenesis IEP 8554631 PMID:10734101 UniProt metanephric glomerular capillary formation ISO RGD:11070 1624291 UniProtKB:P26618 (MGI:MGI:1931346 , PMID:11239463) RGD MGI:MGI:1931346 , PMID:11239463 metanephric glomerular capillary formation ISS UniProtKB:P05622 1600115 GO_REF:0000024 UniProt GO_REF:0000024 metanephric glomerular mesangial cell proliferation involved in metanephros development ISO RGD:11070 1624291 (MGI:MGI:1289803, PMID:9693135) RGD MGI:MGI:1289803 , PMID:9693135 metanephric glomerular mesangial cell proliferation involved in metanephros development ISS UniProtKB:P05622 1600115 GO_REF:0000024 UniProt GO_REF:0000024 metanephric glomerular mesangium development ISO RGD:11070 1624291 (PMID:9693135) RGD PMID:9693135 metanephric glomerulus morphogenesis IEP 8554631 PMID:10734101 UniProt metanephric mesenchymal cell migration IDA 8554631 PMID:10734101 UniProt metanephric mesenchyme development IEP 8554631 PMID:10734101 UniProt metanephric S-shaped body morphogenesis IEP 8554631 PMID:10734101 UniProt multicellular organism development IBA FB:FBgn0003733 more ... 13792537 PMID:21873635 GO_Central negative regulation of apoptotic process IMP 2292205 RGD nitrogen compound metabolic process ISO RGD:11070 1624291 MGI:MGI:2135508 (MGI:MGI:3696608 , PMID:17143286) RGD MGI:MGI:3696608 , PMID:17143286 peptidyl-tyrosine phosphorylation ISO RGD:732897 1624291 (PMID:1653029), (PMID:2536956), (PMID:2850496) RGD PMID:1653029 more ... peptidyl-tyrosine phosphorylation ISS UniProtKB:P09619 1600115 GO_REF:0000024 UniProt GO_REF:0000024 peptidyl-tyrosine phosphorylation ISO RGD:11070 1624291 (MGI:MGI:2680741, PMID:14624252) RGD MGI:MGI:2680741 , PMID:14624252 phosphatidylinositol metabolic process ISO RGD:732897 1624291 (PMID:1653029) RGD PMID:1653029 phosphatidylinositol metabolic process ISS UniProtKB:P09619 1600115 GO_REF:0000024 UniProt GO_REF:0000024 phosphatidylinositol-mediated signaling ISO RGD:732897 1624291 (PMID:2554309) RGD PMID:2554309 phosphatidylinositol-mediated signaling ISS UniProtKB:P09619 1600115 GO_REF:0000024 UniProt GO_REF:0000024 platelet-derived growth factor receptor signaling pathway ISO RGD:732897 1624291 (PMID:1314164), (PMID:2536956) RGD PMID:1314164 , PMID:2536956 platelet-derived growth factor receptor signaling pathway ISO RGD:11070 1624291 MGI:MGI:2135508 (MGI:MGI:3696608 more ... RGD MGI:MGI:3696608 more ... platelet-derived growth factor receptor-beta signaling pathway ISO RGD:732897 1624291 (PMID:2554309), (PMID:26599395) RGD PMID:2554309 , PMID:26599395 positive regulation of apoptotic process IMP 1625382 RGD positive regulation of calcium ion import ISO RGD:11070 1624291 (MGI:MGI:5284758, PMID:19019919) RGD MGI:MGI:5284758 , PMID:19019919 positive regulation of calcium ion import ISS UniProtKB:P05622 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of cell migration ISO RGD:732897 1624291 (PMID:17470632) RGD PMID:17470632 positive regulation of cell migration ISS UniProtKB:P09619 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of cell population proliferation IMP 2292167 RGD positive regulation of cell population proliferation ISO RGD:732897 1624291 (PMID:2554309) RGD PMID:2554309 positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway ISO RGD:732897 1624291 (PMID:17470632) RGD PMID:17470632 positive regulation of chemotaxis ISO RGD:11070 1624291 (MGI:MGI:5284758, PMID:19019919) RGD MGI:MGI:5284758 , PMID:19019919 positive regulation of chemotaxis ISS UniProtKB:P05622 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of collagen biosynthetic process IMP 2292205 RGD positive regulation of DNA biosynthetic process ISO RGD:11070 1624291 (MGI:MGI:5284758, PMID:19019919) RGD MGI:MGI:5284758 , PMID:19019919 positive regulation of DNA biosynthetic process ISS UniProtKB:P05622 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of ERK1 and ERK2 cascade ISO RGD:732897 1624291 (PMID:21679854) RGD PMID:21679854 positive regulation of ERK1 and ERK2 cascade ISS UniProtKB:P09619 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of ERK1 and ERK2 cascade ISS UniProtKB:P05622 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of ERK1 and ERK2 cascade ISO RGD:11070 1624291 (MGI:MGI:2680741 more ... RGD MGI:MGI:2680741 more ... positive regulation of fibroblast proliferation IMP 10449503 RGD positive regulation of hepatic stellate cell activation IMP 10449503 RGD positive regulation of kinase activity IBA PANTHER:PTN001230349 , UniProtKB:Q16832 13792537 PMID:21873635 GO_Central positive regulation of MAP kinase activity ISO RGD:11070 1624291 (MGI:MGI:5009390, PMID:17942966) RGD MGI:MGI:5009390 , PMID:17942966 positive regulation of MAP kinase activity ISS UniProtKB:P05622 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway ISO RGD:11070 1624291 (MGI:MGI:5284758, PMID:19019919) RGD MGI:MGI:5284758 , PMID:19019919 positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway ISS UniProtKB:P05622 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of mitotic nuclear division ISO RGD:11070 1624291 (MGI:MGI:5009390, PMID:17942966) RGD MGI:MGI:5009390 , PMID:17942966 positive regulation of mitotic nuclear division ISS UniProtKB:P05622 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of phosphatidylinositol 3-kinase activity ISO RGD:732897 1624291 (PMID:1314164) RGD PMID:1314164 positive regulation of phosphatidylinositol 3-kinase activity ISS UniProtKB:P09619 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of phosphatidylinositol 3-kinase signaling ISO RGD:11070 1624291 (MGI:MGI:5009390, PMID:17942966) RGD MGI:MGI:5009390 , PMID:17942966 positive regulation of phosphatidylinositol 3-kinase signaling ISS UniProtKB:P05622 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of phospholipase C activity ISO RGD:732897 1624291 (PMID:1653029) RGD PMID:1653029 positive regulation of phospholipase C activity ISS UniProtKB:P09619 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of phosphoprotein phosphatase activity ISO RGD:732897 1624291 (PMID:7691811) RGD PMID:7691811 positive regulation of reactive oxygen species metabolic process ISO RGD:11070 1624291 (MGI:MGI:5284758, PMID:19019919) RGD MGI:MGI:5284758 , PMID:19019919 positive regulation of reactive oxygen species metabolic process ISS UniProtKB:P05622 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of Rho protein signal transduction IMP 10449505 RGD positive regulation of smooth muscle cell migration ISO RGD:732897 1624291 (PMID:21679854) RGD PMID:21679854 positive regulation of smooth muscle cell migration ISS UniProtKB:P09619 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of smooth muscle cell migration ISS UniProtKB:P05622 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of smooth muscle cell migration IBA MGI:MGI:97531 more ... 13792537 PMID:21873635 GO_Central positive regulation of smooth muscle cell migration ISO RGD:11070 1624291 UniProtKB:Q91ZX7 (MGI:MGI:1338343 more ... RGD MGI:MGI:1338343 more ... positive regulation of smooth muscle cell proliferation ISO RGD:732897 1624291 (PMID:21679854) RGD PMID:21679854 positive regulation of smooth muscle cell proliferation ISS UniProtKB:P09619 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of smooth muscle cell proliferation ISS UniProtKB:P05622 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of smooth muscle cell proliferation ISO RGD:11070 1624291 (MGI:MGI:1338343, PMID:10375497) RGD MGI:MGI:1338343 , PMID:10375497 protein autophosphorylation ISO RGD:732897 1624291 (PMID:1314164), (PMID:2536956), (PMID:2850496) RGD PMID:1314164 more ... protein autophosphorylation ISS UniProtKB:P09619 1600115 GO_REF:0000024 UniProt GO_REF:0000024 protein autophosphorylation ISO RGD:11070 1624291 (MGI:MGI:2680741, PMID:14624252) RGD MGI:MGI:2680741 , PMID:14624252 regulation of actin cytoskeleton organization ISO RGD:11070 1624291 UniProtKB:Q91ZX7 (MGI:MGI:4365879 , PMID:19742316) RGD MGI:MGI:4365879 , PMID:19742316 regulation of peptidyl-tyrosine phosphorylation ISO RGD:11070 1624291 (MGI:MGI:2182234, PMID:11940581) RGD MGI:MGI:2182234 , PMID:11940581 response to ceramide ISO RGD:11070 1624291 (MGI:MGI:5518963, PMID:23651497) RGD MGI:MGI:5518963 , PMID:23651497 response to estradiol IEP 2292208 RGD response to estrogen IEP 2292210 RGD response to fluid shear stress IEP 2292209 RGD response to hydrogen peroxide IEP 2292213 RGD response to hyperoxia IEP 1580851 RGD response to lipid IEP 2292207 RGD response to organic cyclic compound IEP 2292204 RGD response to retinoic acid IEP 2292175 RGD response to toxic substance IEP 2292201 RGD retina vasculature development in camera-type eye ISO RGD:11070 1624291 UniProtKB:P26618 (MGI:MGI:1931346 more ... RGD MGI:MGI:1931346 more ... retina vasculature development in camera-type eye ISS UniProtKB:P05622 1600115 GO_REF:0000024 UniProt GO_REF:0000024 ruffle assembly ISO RGD:11070 1624291 (MGI:MGI:5699914, PMID:26437238) RGD MGI:MGI:5699914 , PMID:26437238 signal transduction ISO RGD:732897 1624291 (PMID:10821867) RGD PMID:10821867 signal transduction ISO RGD:11070 1624291 (MGI:MGI:2182234, PMID:11940581) RGD MGI:MGI:2182234 , PMID:11940581 skeletal system morphogenesis ISO RGD:11070 1624291 MGI:MGI:2135508 (MGI:MGI:3696608 , PMID:17143286) RGD MGI:MGI:3696608 , PMID:17143286 smooth muscle cell chemotaxis ISO RGD:11070 1624291 UniProtKB:Q91ZX7 (MGI:MGI:4365879 , PMID:19742316) RGD MGI:MGI:4365879 , PMID:19742316 smooth muscle tissue development ISO RGD:11070 1624291 MGI:MGI:2135508 (MGI:MGI:3696608 , PMID:17143286) RGD MGI:MGI:3696608 , PMID:17143286 tissue homeostasis ISO RGD:11070 1624291 MGI:MGI:2135508 (MGI:MGI:3696608 , PMID:17143286) RGD MGI:MGI:3696608 , PMID:17143286 transmembrane receptor protein tyrosine kinase signaling pathway IBA FB:FBgn0003366 more ... 13792537 PMID:21873635 GO_Central wound healing IEP 2292211 RGD Cellular Component apical plasma membrane IDA 8554477 PMID:10550325 UniProt cell surface IDA 1625382 RGD cell surface ISO RGD:11070 1624291 (MGI:MGI:5520108, PMID:24029230) RGD MGI:MGI:5520108 , PMID:24029230 cytoplasm IDA 2311654 PMID:10802145 UniProt cytoplasm ISO RGD:11070 1624291 (MGI:MGI:5306847 more ... RGD MGI:MGI:5306847 more ... cytoplasm IDA 8554178 PMID:11788434 UniProt cytoplasmic vesicle IEA UniProtKB-KW:KW-0968 1600115 GO_REF:0000043 UniProt GO_REF:0000043 Golgi apparatus IEA UniProtKB:P09619 , ensembl:ENSP000002617991600115 GO_REF:0000107 Ensembl GO_REF:0000107 Golgi apparatus ISO RGD:732897 1624291 RGD GO_REF:0000052 integral component of plasma membrane IBA FB:FBgn0003366 more ... 13792537 PMID:21873635 GO_Central intracellular membrane-bounded organelle ISO RGD:732897 1624291 RGD GO_REF:0000052 intrinsic component of plasma membrane ISO RGD:732897 1624291 (PMID:2554309) RGD PMID:2554309 lysosomal lumen IEA UniProtKB-SubCell:SL-0156 1600115 GO_REF:0000044 UniProt GO_REF:0000044 membrane ISO RGD:732897 1624291 (PMID:16477012) RGD PMID:16477012 membrane ISS UniProtKB:P09619 1600115 GO_REF:0000024 UniProt GO_REF:0000024 nucleus IDA 8554178 PMID:11788434 UniProt plasma membrane IDA 2311654 PMID:10802145 UniProt plasma membrane IDA 8554178 PMID:11788434 UniProt receptor complex IBA FB:FBgn0015380 more ... 13792537 PMID:21873635 GO_Central ruffle ISO RGD:11070 1624291 (MGI:MGI:5699914, PMID:26437238) RGD MGI:MGI:5699914 , PMID:26437238 Molecular Function ATP binding IEA UniProtKB-KW:KW-0067 1600115 GO_REF:0000043 UniProt GO_REF:0000043 enzyme binding ISO RGD:732897 1624291 UniProtKB:O75460 (PMID:26315405) RGD PMID:26315405 growth factor binding IBA MGI:MGI:97530 more ... 13792537 PMID:21873635 GO_Central kinase activity ISO RGD:11070 1624291 (MGI:MGI:2664443, PMID:12808090) RGD MGI:MGI:2664443 , PMID:12808090 phosphatidylinositol 3-kinase binding IPI RGD:3329 4108491 RGD platelet-derived growth factor beta-receptor activity ISO RGD:732897 1624291 (PMID:1314164), (PMID:2536956), (PMID:2554309), (PMID:26599395), (PMID:2850496) RGD PMID:1314164 more ... platelet-derived growth factor beta-receptor activity ISS UniProtKB:P09619 1600115 GO_REF:0000024 UniProt GO_REF:0000024 platelet-derived growth factor beta-receptor activity IBA PANTHER:PTN002814407 , UniProtKB:P09619 13792537 PMID:21873635 GO_Central platelet-derived growth factor binding ISO RGD:732897 1624291 UniProtKB:P01127 (PMID:2536956), (PMID:2554309), (PMID:2850496) RGD PMID:2536956 more ... platelet-derived growth factor binding IBA PANTHER:PTN002814407 , UniProtKB:P09619 13792537 PMID:21873635 GO_Central platelet-derived growth factor receptor binding ISO RGD:732897 1624291 UniProtKB:P16234 (PMID:2542288) RGD PMID:2542288 platelet-derived growth factor-activated receptor activity IDA 1581762 ; 633648 RGD platelet-derived growth factor-activated receptor activity ISO RGD:11070 1624291 (MGI:MGI:5699914, PMID:26437238) RGD MGI:MGI:5699914 , PMID:26437238 platelet-derived growth factor-activated receptor activity IBA MGI:MGI:97531 more ... 13792537 PMID:21873635 GO_Central platelet-derived growth factor-activated receptor activity TAS 628442 RGD protein binding IPI RGD:67383 2292213 RGD protein binding ISO RGD:732897 1624291 UniProtKB:O14745 more ... RGD PMID:10336465 more ... protein binding IPI RGD:3537 10002733 RGD protein binding IPI UniProtKB:Q9WUD9 8553998 PMID:16530387 UniProt protein binding ISO RGD:11070 1624291 UniProtKB:C5IAU5 more ... RGD MGI:MGI:3617099 more ... protein kinase activity TAS 628442 RGD protein kinase binding ISO RGD:732897 1624291 UniProtKB:P06241 , UniProtKB:P12931 (PMID:16479011) RGD PMID:16479011 protein tyrosine kinase activity TAS 628442 RGD protein tyrosine kinase activity IDA 8553998 PMID:16530387 UniProt protein tyrosine kinase activity ISO RGD:732897 1624291 (PMID:1653029) RGD PMID:1653029 signaling receptor binding ISO RGD:732897 1624291 UniProtKB:Q12913 (PMID:10821867) RGD PMID:10821867 signaling receptor binding ISO RGD:11070 1624291 UniProtKB:P05622 (MGI:MGI:3617099 , PMID:16456542) RGD MGI:MGI:3617099 , PMID:16456542 transmembrane receptor protein tyrosine kinase activity IBA FB:FBgn0003366 more ... 13792537 PMID:21873635 GO_Central vascular endothelial growth factor binding ISO RGD:732897 1624291 UniProtKB:P15692 (PMID:17470632) RGD PMID:17470632
Gene-Chemical Interaction Annotations
